Nebenwirkungen · Riximyo
Riximyo 100 mg concentrate for solution for infusion Riximyo 500 mg concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 23
HOS-141059 · Präparat HOS-098602
MedDRA Not known System organ Very common Common Uncommon Rare Very rare class Infections and Upper Bronchitis, PML, serious viral infestations respiratory sinusitis, reactivatio infection1, 2, tract infection, gastroenteritis, n of enteroviral urinary tract tinea pedis hepatitis B meningoenc infections ephalitis2 Blood and Neutropenia3 Late Serum lymphatic neutropenia4 sickness- system disorders like reaction 5 5 Immune system Infusion- Infusion- disorders related related General reactions reactions disorders and (hypertension, (generalised administration nausea, rash, oedema, site conditions pyrexia, bronchospasm, pruritus, wheezing, urticaria, throat laryngeal irritation, hot oedema, flush, angioneurotic hypotension, oedema, rhinitis, rigors, generalised tachycardia, pruritus, fatigue, anaphylaxis, oropharyngeal anaphylactoid pain, oedema reaction) peripheral, erythema) Metabolism and Hypercholeste nutrition rolemia disorders Psychiatric Depression, disorders anxiety Nervous system Headache Paraesthesia, disorders migraine, dizziness, sciatica
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-09-04T16:41:00Z · SHA-256 4fe21e50fef50537643123868d3f044762b7d55eab7d50a56c1d469305291ee4 · Passage 3ebccac18cbaa486cd4145f53c625bcbafc5fb0bb2bd2958c2c810d4c7aa49dc · Zeichen 28304–31191 im Abschnitt